Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Osteotech stops polymer research:

This article was originally published in Clinica

Executive Summary

Osteotech has discontinued its polymer R&D programme which included the development of an adhesion barrier and an artificial skin product. Furthermore, the company has stopped marketing its OsteoActive bone substitute. The bone void filler was launched in Europe in late 1995. The measures are part of a restructuring programme to cut spending by more than $1 million a year and to make the European operations profitable. Osteotech will focus on building its revenues by producing ceramic and titanium plasma spray coating services and ceramic powders and products.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT089370

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel